Denali Therapeutics OverviewDenali Therapeutics Other Income Expense Net
Other Income/Expense Net for DNLI.
Quarterly Other Income/Expense
$8.91M
↓ 29.34% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$39.20M
↓ 36.08% YoY
Trailing 12 months ending Mar 31, 2026